Effect of influenza A/equine/H3N8 virus isolate variation on the measurement of equine antibody responses
- PMID: 8387870
- PMCID: PMC1263606
Effect of influenza A/equine/H3N8 virus isolate variation on the measurement of equine antibody responses
Abstract
This study has tested the effect of using homologous or heterologous equine influenza A virus isolates to evaluate serum antibody levels to influenza A virus in vaccinated and naturally-infected horses. In addition, the potential effect of antigenic selection of virus variants in egg versus tissue culture propagation systems was studied. Serum antibody levels in samples from horses recently infected with a local influenza A virus isolate (A/equine 2/Saskatoon/1/90) or recently vaccinated with a prototype isolate (A/equine 2/Miami/1/63) were assessed by hemagglutination inhibition and by single radial hemolysis using cell or egg-propagated A/equine 2/Saskatoon/1/90, A/equine 2/Miami/1/63 or A/equine 2/Fontainebleau/1/79. There were no significant differences in hemagglutination inhibition or single radial hemolysis antibody levels obtained with homologous or heterologous isolates or between viruses propagated in either eggs or cell culture. However there was a trend to higher titers in the hemagglutination inhibition assay when cell-propagated virus was used. These results suggest that antigenic variation in equine influenza A virus isolates and host-cell selection of antigenic variants during virus propagation may not be of sufficient magnitude to influence serological evaluation of antibody responses by hemagglutination inhibition or single radial hemolysis.
Similar articles
-
Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus.Vet Immunol Immunopathol. 2006 Aug 15;112(3-4):225-33. doi: 10.1016/j.vetimm.2006.02.007. Epub 2006 Apr 18. Vet Immunol Immunopathol. 2006. PMID: 16621023
-
Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.Vet Res. 2008 May-Jun;39(3):21. doi: 10.1051/vetres:2007062. Epub 2008 Feb 7. Vet Res. 2008. PMID: 18252187 Clinical Trial.
-
Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus.Vaccine. 2004 Dec 2;23(3):418-25. doi: 10.1016/j.vaccine.2004.01.074. Vaccine. 2004. PMID: 15530689
-
Vaccination against equine influenza: quid novi?Vaccine. 2006 May 8;24(19):4047-61. doi: 10.1016/j.vaccine.2006.02.030. Epub 2006 Feb 28. Vaccine. 2006. PMID: 16545507 Review.
-
Current perspectives on control of equine influenza.Vet Res. 2004 Jul-Aug;35(4):411-23. doi: 10.1051/vetres:2004023. Vet Res. 2004. PMID: 15236674 Review.
Cited by
-
Equine Influenza Virus and Vaccines.Viruses. 2021 Aug 20;13(8):1657. doi: 10.3390/v13081657. Viruses. 2021. PMID: 34452521 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources